Clinical Trials
10
Active:1
Completed:6
Trial Phases
4 Phases
Phase 1:1
Phase 3:1
Phase 4:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (40.0%)Phase 1
1 (20.0%)Phase 3
1 (20.0%)Phase 4
1 (20.0%)Cryotherapy Reduces Time to Surgery and Local Complication in Patients With Ankle Fractures
Not Applicable
Completed
- Conditions
- Ankle Fractures
- First Posted Date
- 2024-05-02
- Last Posted Date
- 2024-05-02
- Lead Sponsor
- Azienda Ospedaliera San Camillo Forlanini
- Target Recruit Count
- 169
- Registration Number
- NCT06396364
- Locations
- 🇮🇹
A.O. San Camillo Forlanini, Rome, Italy
🇮🇹A.O. San camillo Forlanini, Rome, Italy
Impact of Two Medtronic Infusion Sets on Lipohypertrophy in Type 1 Diabetes (T1DM) Patients Thought to Have LH
Not Applicable
Completed
- Conditions
- DiabetesLipohypertrophyDiabetes Mellitus, Type 1
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Azienda Ospedaliera San Camillo Forlanini
- Target Recruit Count
- 16
- Registration Number
- NCT06074965
- Locations
- 🇮🇹
Azienda Ospedaliera San Camillo Forlanini, Roma, Italy
iFR-guided Revascularization in STEMI
- Conditions
- ST Segment Elevation Myocardial Infarction
- First Posted Date
- 2018-06-19
- Last Posted Date
- 2020-01-18
- Lead Sponsor
- Azienda Ospedaliera San Camillo Forlanini
- Target Recruit Count
- 200
- Registration Number
- NCT03561389
- Locations
- 🇮🇹
Ospedale San Camillo, Roma, Italy
Instantaneous Wave-Free Ratio and Fractional Flow Reserve for the Assessment of Non Culprit Lesions in Patients With ST-segment Elevation Myocardial Infarction
- Conditions
- ST Segment Elevation Myocardial Infarction
- First Posted Date
- 2016-08-17
- Last Posted Date
- 2016-08-17
- Lead Sponsor
- Azienda Ospedaliera San Camillo Forlanini
- Target Recruit Count
- 60
- Registration Number
- NCT02869906
- Locations
- 🇮🇹
Ospedale San Camillo, Rome, Italy
Sofosbuvir/Simeprevir Plus a Flat Dose of Ribavirin in Genotype 1 Elderly HCV Cirrhotic Patients
Phase 4
Completed
- Conditions
- Liver Cirrhosis
- Interventions
- First Posted Date
- 2016-03-09
- Last Posted Date
- 2016-03-09
- Lead Sponsor
- Azienda Ospedaliera San Camillo Forlanini
- Target Recruit Count
- 270
- Registration Number
- NCT02702739
- Locations
- 🇮🇹
AO San Camillo Forlanini, Rome, Italy
- Prev
- 1
- 2
- Next
News
No news found